Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-6214

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-6214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Venlafaxine Hydrochloride (Image 1)

Chemical structure of venlafaxine hydrochloride, showing its molecular framework including a methoxyphenyl group, dimethylamino group, cyclohexanol ring, and hydrochloride component.*

FDA Label Image

1 (Image 2)

A dot plot chart showing fold changes and 90% confidence intervals for venlafaxine and its ODV metabolite pharmacokinetics (Cmax and AUC) across various special populations. Populations include hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism status, age over 60 years, and gender. The x-axis represents change relative to a reference value, ranging from 0 to 3.5 fold.*

FDA Label Image

2 (Image 3)

A scatter plot illustrating fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax, AUC, ODV) for venlafaxine when co-administered with various interacting drugs including Ethanol, Diazepam, Cimetidine, Ketoconazole in CYP2D6 EMs and PMs, Indinavir, Metoprolol, Imipramine, and Lithium. The x-axis represents change relative to the reference value ranging approximately from 0 to 3.*

FDA Label Image

3 (Image 4)

A chart depicting drug interaction effects on analyte pharmacokinetics (Cmax and AUC) for various interacting drugs, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The graph plots fold change and 90% confidence intervals relative to a reference value with a horizontal axis ranging from 0 to 3.*

FDA Label Image

Label Image (Lbl500906214)

Venlafaxine Hydrochloride 75 mg extended release oral capsules label from A-S Medication Solutions. The label includes the product name, strength, dosage form, storage instructions (store at 60 to 77 degrees F), quantity (30 capsules), NDC 50090-6214-0, and lot number 6226-0. It also states that each capsule contains venlafaxine hydrochloride equivalent to 75 mg venlafaxine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.